Remember when a blood test meant a morning at the hospital, fasting, and waiting days for results? Not anymore. At‑home rapid tests for glucose, pregnancy, and even COVID have changed everything. The China rapid diagnostics market report by MRFR shows that over‑the‑counter (OTC) kits are the largest product segment, and the whole market is growing at 8.79% CAGR — from $2.83 billion to $7.15 billion by 2035. Why? Because convenience is king, and Chinese consumers are tech‑savvy.

What's driving OTC growth? Diabetes management (glucose testing), pregnancy testing, and infectious disease screening. The China rapid diagnostics market analysis highlights that blood glucose testing is the largest application, but infectious disease testing is the fastest‑growing — because outbreaks (flu, COVID, monkeypox) have made people hyper‑aware of early detection.

Professional kits (used in hospitals) are still essential, but OTC kits are growing faster. Why? Because they're cheap ($5‑$20), easy to use, and private. You don't need a doctor's order or an appointment.

The bottom line: if you have a chronic condition like diabetes, an OTC rapid test can be a lifesaver. But remember, they're not perfect. False negatives happen. If you have symptoms, see a doctor. Don't trust a stick blindly.